Da An Gene Co Ltd of Sun Yat-Sen University (002030) - Total Liabilities
Based on the latest financial reports, Da An Gene Co Ltd of Sun Yat-Sen University (002030) has total liabilities worth CN¥1.07 Billion CNY (≈ $156.22 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Da An Gene Co Ltd of Sun Yat-Sen Univers's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Da An Gene Co Ltd of Sun Yat-Sen University - Total Liabilities Trend (2001–2025)
This chart illustrates how Da An Gene Co Ltd of Sun Yat-Sen University's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Da An Gene Co Ltd of Sun Yat-Sen Univers.
Da An Gene Co Ltd of Sun Yat-Sen University Competitors by Total Liabilities
The table below lists competitors of Da An Gene Co Ltd of Sun Yat-Sen University ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
City Development Environment Co Ltd
SHE:000885
|
China | CN¥21.52 Billion |
|
Kunshan Guoli Electronic Technology Co Ltd
SHG:688103
|
China | CN¥1.55 Billion |
|
Bank Leumi Le-Israel B.M
TA:LUMI
|
Israel | ILA835.01 Billion |
|
Siam Global House Public Company Limited
BK:GLOBAL
|
Thailand | ฿14.40 Billion |
|
PORR AG
VI:POS
|
Austria | €3.57 Billion |
|
Financial Street Holdings Co Ltd
SHE:000402
|
China | CN¥82.27 Billion |
|
Isras Investment Company Ltd
TA:ISRS
|
Israel | ILA5.80 Billion |
|
Bowhead Specialty Holdings Inc.
NYSE:BOW
|
USA | $2.21 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down Da An Gene Co Ltd of Sun Yat-Sen University's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 002030 net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Da An Gene Co Ltd of Sun Yat-Sen University's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Da An Gene Co Ltd of Sun Yat-Sen University (2001–2025)
The table below shows the annual total liabilities of Da An Gene Co Ltd of Sun Yat-Sen University from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.15 Billion ≈ $167.66 Million |
-20.10% |
| 2024-12-31 | CN¥1.43 Billion ≈ $209.82 Million |
-22.94% |
| 2023-12-31 | CN¥1.86 Billion ≈ $272.30 Million |
-40.76% |
| 2022-12-31 | CN¥3.14 Billion ≈ $459.65 Million |
+17.36% |
| 2021-12-31 | CN¥2.68 Billion ≈ $391.65 Million |
+22.47% |
| 2020-12-31 | CN¥2.19 Billion ≈ $319.79 Million |
+48.25% |
| 2019-12-31 | CN¥1.47 Billion ≈ $215.71 Million |
+0.78% |
| 2018-12-31 | CN¥1.46 Billion ≈ $214.05 Million |
-26.87% |
| 2017-12-31 | CN¥2.00 Billion ≈ $292.68 Million |
+26.07% |
| 2016-12-31 | CN¥1.59 Billion ≈ $232.15 Million |
+43.96% |
| 2015-12-31 | CN¥1.10 Billion ≈ $161.26 Million |
+63.13% |
| 2014-12-31 | CN¥675.55 Million ≈ $98.85 Million |
+70.13% |
| 2013-12-31 | CN¥397.08 Million ≈ $58.11 Million |
+38.80% |
| 2012-12-31 | CN¥286.08 Million ≈ $41.86 Million |
+23.75% |
| 2011-12-31 | CN¥231.17 Million ≈ $33.83 Million |
+20.77% |
| 2010-12-31 | CN¥191.41 Million ≈ $28.01 Million |
+22.25% |
| 2009-12-31 | CN¥156.57 Million ≈ $22.91 Million |
+8.29% |
| 2008-12-31 | CN¥144.59 Million ≈ $21.16 Million |
+23.88% |
| 2007-12-31 | CN¥116.72 Million ≈ $17.08 Million |
+157.16% |
| 2006-12-31 | CN¥45.39 Million ≈ $6.64 Million |
+67.17% |
| 2005-12-31 | CN¥27.15 Million ≈ $3.97 Million |
-51.73% |
| 2004-12-31 | CN¥56.25 Million ≈ $8.23 Million |
-33.31% |
| 2003-12-31 | CN¥84.35 Million ≈ $12.34 Million |
+37.12% |
| 2002-12-31 | CN¥61.51 Million ≈ $9.00 Million |
+25.01% |
| 2001-12-31 | CN¥49.21 Million ≈ $7.20 Million |
-- |
About Da An Gene Co Ltd of Sun Yat-Sen University
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers PCR testing kits, including hepatitis virus, human papillomavirus (HPV), sexually transmitted infections … Read more